Stock Analysis, Dividends, Split History

THLD / Threshold Pharmaceuticals, Inc. financial ratios include Market Cap, Enterprise Value, Book Value, Quick Ratio, Current Ratio, NCAV, EBITDA, Profit Margin, Operating Margin, Return on Invested Capital (ROIC), Return on Assets (ROA), Return on Equity (ROE), Piotroski F-Score, Altman Z-Score, Beneish M Score and Kaplan-Zingales KZ-Index.

Valuation Metrics
Price0.54
Volume1,419,200.00
Market Cap ($M)14.62
Enterprise Value ($M)-23.93
Book Value ($M)62.18
Book Value / Share2.30
Price / Book0.24
NCAV ($M)26.91
NCAV / Share0.99
Price / NCAV0.54
Share Statistics
Common Stock Shares Outstanding 26,898,330
Common Shares Outstanding 27,058,244
Scoring Models
Piotroski F-Score3.00
Altman Z ScoreN/A
Beneish M ScoreN/A
Management Effectiveness (mra)
Return on Invested Capital (ROIC)-0.28
Return on Assets (ROA)-0.95
Return on Equity (ROE)-1.16
Balance Sheet (mrq) ($M)
Assets79.42
Liabilities17.24
Quick Ration/a
Current Ratio3.33
Income Statement (mra) ($M)
Contracts Revenue0.00
Revenues3,395,000.00
Research And Development Revenues From Collaboration Agreements2,408,000.00
Revenue From Grants987,000.00
Operating Income-17.85
Net Income-23.14
Earnings Per Share Diluted-2.11
Earnings Per Share Basic-2.11
Earnings Per Share Basic And Diluted-2.11
Cash Flow Statement (mra) ($M)
Cash From Operations-14.26
Cash from Investing9.71
Cash from Financing-14.26
Identifiers and Descriptors
CUSIP608550109
Central Index Key (CIK)1183765
Related CUSIPS
885807906 885807956

Split History

Stock splits are used by Threshold Pharmaceuticals, Inc. to keep share prices within reasonable numbers to encourage investment. If the share price of a security gets too high, a company can perform a stock split by issuing all shareholders an extra share, thereby halving the price of an individual share. If the share price gets too low, companies can do reverse splits. This is common when share prices drop below $1.00 and company's become in danger of being delisted. However, because of the cost, stock splits are not a normal business occurrence.

Coming soon

Related News Stories

Molecular Templates: Takeda News Provides Further Validation

2018-09-21 seekingalpha
Even after Wednesday's big move, shares have lost roughly a third of their value thus far in 2018. (1-2)

CUSIP: 608550109